Acylcarnitine metabolomic profiles inform clinically-defined major depressive phenotypesRead Full Text
Sets of coregulated serum lipids are associated with Alzheimer's disease pathophysiology.
Bile acids targeted metabolomics and medication classification data in the ADNI1 and ADNIGO/2 cohorts.
Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients.
Association of Altered Liver Enzymes With Alzheimer Disease Diagnosis, Cognition, Neuroimaging Measures, and Cerebrospinal Fluid Biomarkers.
T126. Short- Vs Medium + Long-Chain Plasma Acylcarnitine in Phenotypes of Major Depression at Baseline and After Citalopram/Escitalopram TreatmentRead Full Text
Altered bile acid profile in mild cognitive impairment and Alzheimer's disease: Relationship to neuroimaging and CSF biomarkers.
Altered bile acid profile associates with cognitive impairment in Alzheimer's disease-An emerging role for gut microbiome.
Datenbasierte Funktionsvorhersage krankheitsrelevanter genetischer VariantenRead Full Text
PhenoDis: a comprehensive database for phenotypic characterization of rare cardiac diseases.
Brain and blood metabolite signatures of pathology and progression in Alzheimer disease: A targeted metabolomics study.
Targeted metabolomics and medication classification data from participants in the ADNI1 cohort.
Metabolic network failures in Alzheimer's disease: A biochemical road map.
Connecting genetic risk to disease end points through the human blood plasma proteome.
Candidate gene variants of the immune system and sudden infant death syndrome.
Genome-Wide Association Study with Targeted and Non-targeted NMR Metabolomics Identifies 15 Novel Loci of Urinary Human Metabolic Individuality.
SNiPA: an interactive, genetic variant-centered annotation browser.
An atlas of genetic influences on human blood metabolites.
Genome-wide association studies in asthma: what they really told us about pathogenesis.
Network-based SNP meta-analysis identifies joint and disjoint genetic features across common human diseases.
[Multicomponent therapy of fibromyalgia syndrome. Systematic review, meta-analysis and guideline].
Cis-acting polymorphisms affect complex traits through modifications of microRNA regulation pathways.